SPTBN2通过促进SLC7A11膜贩运和局部化,抑制NSCLC细胞中的铁亡

Jun Deng1, Xu Lin2, Jiajia Qin3

  • 1Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China; Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, GuangXi, 530021, China.

Redox biology
|January 19, 2024
PubMed
概括

在非小细胞肺癌 (NSCLC) 中,SPTBN2通过调节SLC7A11膜局部化来抑制铁. 抑制SPTBN2增强了思丁的敏感性,为NSCLC治疗提供了潜在的治疗策略.